Bacopaside II is a potential anti-angiogenic agent, it can reduce endothelial cell migration and tubulogenesis and induce apoptosis.

Bacoside A3 has antioxidant potential, it shows comparatively higher neuroprotective response analysed as higher cell viability and decreased intracellular ROS.

Bacopaside I is a saponin isolated from Bacopa monniera. Bacopaside I is a modulator of Aquaporin-1 channel, has neuroprotective functions, it has anti-Alzheimer's disease, it ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of α2-amyloid,exbibits antioxidant properties and free radical scavenging capacity and exerts antidepressant-like effect.

Bacopasaponin C may have antioxidant activity, it also shows anti-leishmanial property.

Bacoside A has a possible anticancer activity that could be inducing cell cycle arrest and apoptosis through Notch pathway in GBM in vitro. It exerts cytoprotective efficacy by attenuation of ROS generated through oxidative stress by an increase in the concentration of antioxidant enzymes and sustain membrane integrity which leads to restoring the damage caused by tBHP. Bacoside A can able to inhibit the progression of Experimental Autoimmune Encephalomyelitis (EAE) may be by the inhibition of inflammatory cytokines and chemokine evolved during active EAE. Bacoside A also has vasorelaxation.

Bacopaside V is a natural product

Bacopaside N2 is a natural product

Bacosine is a natural product for research related to life sciences. The catalog number is TN3479 and the CAS number is 198014-94-7.

Bacopaside IV is a natural product for research related to life sciences. The catalog number is TN3478 and the CAS number is 155545-03-2.

Bacopaside X is a triterpenoid saponin isolated from Bacopa monniera that exhibits strong antifungal and anticancer activities by actively suppressing pathogenic fungal growth and tumor progression, demonstrated through inhibition of Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus at MIC values of 50 µg/ml, along with significantly decreasing proliferation in cancer cell lines MDA-MB-231, SHG44, HCT8, A549, and PC3M with IC50 values of 14.3, 15.9, 9.8, 9.7, and 10.1 µM respectively. Bacopaside X additionally reduces tumor growth by 84.13% in an S180 sarcoma mouse allograft model when administered at a dose of 50 µmol/kg, indicating substantial therapeutic potential.